Key statistics
On Monday, Gain Therapeutics Inc (GANX:NMQ) closed at 2.71, 92.20% above the 52 week low of 1.41 set on Aug 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.60 |
|---|---|
| High | 2.74 |
| Low | 2.48 |
| Bid | 2.67 |
| Offer | 2.72 |
| Previous close | 2.61 |
| Average volume | 837.90k |
|---|---|
| Shares outstanding | 38.46m |
| Free float | 37.15m |
| P/E (TTM) | -- |
| Market cap | 100.39m USD |
| EPS (TTM) | -0.6364 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
- Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
- Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
- Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
- Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025
- Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update
- Gain Therapeutics to Present at Neuroscience 2025
- Gain Therapeutics to Attend the 2025 Maxim Growth Summit
- Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
More ▼
